SWK Holdings Corporation 9.00% Senior Notes due 2027

SWK Holdings Corporation 9.00% Senior Notes due 2027

SWKHL
SWK Holdings Corporation 9.00% Senior Notes due 2027US flagNASDAQ Global Market
25.62
USD
+0.02
- -
309.87MMarket Cap
SWK Holdings Corporation 9.00% Senior Notes due 2027
SWKHL
(NASDAQ Global Market)

Recent

price

25.62

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available
Business
SWK Holdings Corporation serves as a diversified financial services company focused on providing structured debt and equity financing solutions to life sciences companies, medical device manufacturers, and healthcare service providers. The company offers senior and subordinated debt financing; royalty monetization and acquisition services; equity investments in private and public companies; and lending services through its subsidiaries, including SWK Funding LLC and Palantir Technologies Inc. (no relation to the technology firm). Headquartered in King of Prussia, Pennsylvania, SWK Holdings was founded in 1997 as a spin-off from Stanley Works and operates primarily in the United States with investments spanning North America. Its target markets include biotechnology firms, pharmaceutical developers, and healthcare innovators seeking non-dilutive capital. In recent developments, SWK Holdings issued 9.00% Senior Notes due 2027 (ticker: SWKHL) to bolster its lending capacity; expanded its portfolio through new royalty acquisitions in the biopharma sector in 2024; and formed strategic lending partnerships with emerging medtech companies amid rising demand for specialized financing.